Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity [0.03%]
氯吡格雷脱敏治疗噻吩并吡啶类药物过敏患者方案
Nicholas E Walker,Mary B Fasano,Ryan A Hobbs et al.
Nicholas E Walker et al.
The antiplatelet agent clopidogrel has become a mainstay of treatment of patients with acute coronary syndromes and strokes, and to reduce ischemic complications after percutaneous coronary and peripheral interventions. As the use of this a...
Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent [0.03%]
药物洗脱支架置入后的氯吡格雷过敏反应病例报告
Bhadriraju Satish,Kellogg Tressa,Chandra R Harish
Bhadriraju Satish
Antiplatelet agents are indicated after coronary stenting to prevent stent thrombosis and these should not be inadvertently discontinued after stenting. Adverse effects from the use of these drugs may require use of alternative agents.
Critical pathways for the management of stroke and intracerebral hemorrhage: a survey of US hospitals [0.03%]
美国医院对卒中和脑出血管理的评估调查
David Cooper,Edward Jauch,Matthew L Flaherty
David Cooper
Background and purpose: Thirty-day mortality rates in patients with spontaneous intracerebral hemorrhage (ICH) range from 35% to 50%, with only 10-20% of the survivors regaining functional independence. This high mortalit...
Medical therapy for symptomatic heart failure: a contemporary treatment algorithm [0.03%]
症状性心力衰竭的药物治疗：当代治疗方法流程图
Stephanie M Coronel,Mori J Krantz
Stephanie M Coronel
Karol Watson
Karol Watson
Cardiometabolic risk encompasses a cluster of risk factors that may predispose individuals to cardiovascular disease and type 2 diabetes. These risk factors, some of which are currently undermanaged in clinical practice, involve multiple pa...
Critical pathway for management of pacemaker and implantable cardioverter-defibrillator advisories [0.03%]
起搏器和植入式复律除颤器缺陷的管理路径—— critical pathways for the management of pacemaker and implantable cardioverter defibrillator advisories
Mitesh S Amin,Kenneth A Ellenbogen
Mitesh S Amin
Marko Remmel,Franz Hartmann,Lars C Harland et al.
Marko Remmel et al.
Long-term results of recent landmark trials document both benefits and risks of drug-eluting stents (DES) for coronary revascularization. Interestingly, the conclusions drawn from these data vary widely since significant differences in DES ...
The value of bedside cardiac multibiomarker assay in rapid and accurate diagnosis of acute coronary syndromes [0.03%]
床旁心脏多生物标志物测定在急性冠脉综合征快速准确诊断中的价值评估
Shahriar Dadkhah,Korosh Sharain,Roza Sharain et al.
Shahriar Dadkhah et al.
For emergency department physicians, timely triage and risk stratification of chest pain patients remains a challenge. Faced with an aging population and the growing prevalence of heart disease, clinicians are seeking more effective ways to...
An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registry [0.03%]
一项针对心血管病患者或具有相关危险因素患者的年度前瞻性国际研究：CardioMonitor登记数据库的设计和方法学
Benjamin A Steinberg,Christie M Ballantyne,Deepak L Bhatt et al.
Benjamin A Steinberg et al.
Objective: To assess penetration and patterns of treatments in outpatients with cardiovascular disease (CVD) or risk factors. Study: An...
Keith C Ferdinand,Annemarie M Armani
Keith C Ferdinand
The prevalence of hypertension in blacks in the United States is among the highest in the world. Compared with whites, blacks develop hypertension at an earlier age, their average blood pressures are much higher and they experience worse di...